Gts Securities LLC Ardelyx, Inc. Transaction History
Gts Securities LLC
- $46.5 Billion
- Q2 2024
A detailed history of Gts Securities LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 73,800 shares of ARDX stock, worth $474,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,800
Previous 115,300
35.99%
Holding current value
$474,534
Previous $841,000
35.08%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARDX
# of Institutions
209Shares Held
144MCall Options Held
1.01MPut Options Held
1.43M-
Janus Henderson Group PLC London, X025.9MShares$167 Million0.11% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$87.8 Million0.0% of portfolio
-
State Street Corp Boston, MA12MShares$76.9 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C36.9MShares$44.4 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $994M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...